Insider trade

Argan, Inc. (AGX): Director sold ~$725K

Peter W Getsinger, Director at Argan, Inc., sold ~$725K of Argan, Inc. shares.

~$725K
Approx. value · 5,000 sh @ $145.03
11K
Holds after · shares reported
Traded
Apr 16, 2025
Filed
Apr 17, 2025

What stands out in this filing

  • The sale was 30.3% of the shares this insider held before it; the filing reports 11,496 shares afterwards.
  • 5,000 shares at an average of $145.03 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 23, 2024InsiderCEO sold ~$70K of AGX shares in the open market
  2. Apr 1, 2025InsiderDirector sold ~$3.23M of AGX shares in the open market
  3. Apr 2, 2025InsiderDirector sold ~$547K of AGX shares in the open market
  4. Apr 14, 2025InsiderDirector sold ~$345K of AGX shares in the open market
  5. Apr 16, 2025 · this disclosureInsiderDirector sold ~$725K of AGX shares in the open market

What came next

  1. Apr 30, 2025InsiderCFO sold ~$238K of AGX shares in the open market
  2. Jun 9, 2025Insider · 3 peopleInsiders: 3 sales (~$2.0M)
  3. Jun 10, 2025InsiderDirector sold ~$8.32M of AGX shares in the open market
  4. Jun 11, 2025Insider · 3 peopleInsiders: 3 sales (~$8.7M)
  5. Jun 12, 2025InsiderDirector sold ~$3.31M of AGX shares in the open market
  6. Jun 26, 2025InsiderDirector sold ~$733K of AGX shares in the open market
  7. Jun 27, 2025InsiderDirector sold ~$896K of AGX shares in the open market
  8. Jun 30, 2025InsiderDirector sold ~$1.69M of AGX shares in the open market
  9. Jul 29, 2025InsiderDirector sold ~$618K of AGX shares in the open market
  10. Jul 30, 2025InsiderDirector sold ~$469K of AGX shares in the open market
  11. Jul 31, 2025InsiderCFO sold ~$389K of AGX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Argan, Inc.

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGX page.

Other recent filings by Peter W Getsinger, Director

The full history of Peter W Getsinger, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Argan, Inc. (AGX) insider traded, and how much?

Peter W Getsinger, Director at Argan, Inc., sold ~$725K of Argan, Inc. shares. 5,000 shares at $145.03.

When did it happen, and when was it made public?

Traded: Apr 16, 2025. Filed: Apr 17, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale was 30.3% of the shares this insider held before it; the filing reports 11,496 shares afterwards. 5,000 shares at an average of $145.03 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Argan, Inc. recently?

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AGX page.

Does this mean AGX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Argan, Inc.

Everything OQRO holds on this company is on its AGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data